Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Surgery

Gastroenterology

Show all topics

DOI

10.1001/jamaoncol.2020.4515

License

CC-BY-NC-ND

Other Formats

PDF